Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Metallomics. 2010 Feb;2(2):112-6. doi: 10.1039/b917141j. Epub 2009 Oct 27.

Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery.

Author information

  • 1Burnett School of Biomedical Science, College of Medicine, University of Central Florida, Orlando, FL, USA. wself@mail.ucf.edu.

Abstract

Selenoproteins play a wide range of roles in metabolism and oxidative stress defense and are produced by organisms in all three domains of life. Recent evidence has been presented that metal based cancer drugs target the selenol nucleophile of the active site selenocysteine in thioredoxin reductase isoenzymes. Other metals and metalloids, such as tin, arsenic and gold, have also recently been shown to form stable complexes with hydrogen selenide, a required precursor for the synthesis of selenoproteins in all biological organisms. Moreover these metal based compounds have been shown to inhibit growth of pathogens such as Clostridium difficile and Treponema denticola due to their reactivity with this highly reactive metabolic precursor. This review summarizes the recent finding on these two avenues for drug discovery, and puts this work in context with the larger field of selenium biology.

PMID:
21069141
[PubMed - indexed for MEDLINE]
PMCID:
PMC3039543
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Royal Society of Chemistry Icon for PubMed Central
    Loading ...
    Write to the Help Desk